fda semaglutide warning november 2025 Semaglutide: The Drug of Today and a Steppingstone to Tomorrow

We're warning consumers of concerns with compounded medications containing semaglutide: https://www.fda .gov/drugs/postmarket-drug-safety-information-patients-and-providers/medications-containing- semaglutide-marketed-type-2-diabetes-or-weight-loss

23.29

★★★★☆4.8 (126)

Compounded "semaglutide" is not FDA-approved

20.55

★★★★★4.9 (98)

The New York Times spotlighted MEDVi. The FDA had already warned the self-proclaimed 'fastest growing company in history.'

27.38

★★★★★5.0 (157)

FDA Drug Recalls and Warnings: Illegal GLP-1 Sales and Misleading Marketing by Novo Nordisk and Eli Lilly

23.10

★★★★★4.7 (84)

The Therapeutic Goods Administration has issued an urgent safety warning over the risk of suicidal thoughts linked to popular drugs used to treat type 2 diabetes and obesity. The affected drugs include: -

29.18

★★★★★4.9 (203)

FDA warns consumers not to use counterfeit Ozempic (semaglutide) found in the U.S. drug supply chain. The agency recently seized dozens of units of counterfeit Ozempic (semaglutide) injection 1 mg that were

23.96

★★★★★5.0 (176)

Ozempic Lawsuits: Possible Compensation For Damages

23.32

★★★★★4.8 (132)